Effect of cytokine growth factors on the prevention of acute wound failure.
D000818:Animals; D016207:Cytokines / Q000008:administration & dosage; D005205:Fascia / Q000187:drug effects / Q000502:physiology; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage; D006133:Growth Substances / Q000008:administration & dosage*; D006555:Hernia, Ventral / Q000517:prevention & control*; D007273:Injections, Intramuscular; D007375:Interleukin-1 / Q000008:administration & dosage; D023421:Models, Animal; D051381:Rats; D017207:Rats, Sprague-Dawley; D013529:Surgical Wound Dehiscence / Q000517:prevention & control*; D016212:Transforming Growth Factor beta / Q000008:administration & dosage; D053781:Transforming Growth Factor beta2; D014945:Wound Healing / Q000187:drug effects*
D016207:Cytokines; D006133:Growth Substances; D007375:Interleukin-1; D016212:Transforming Growth Factor beta; D053781:Transforming Growth Factor beta2; D016222:Fibroblast Growth Factor 2